Menu

Recent Interviews

Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


Stephan Dorfmeister, Finance Department, Deep Nature Project GmbH

Stephan Dorfmeister
Finance Department | Deep Nature Project GmbH
Untere Hauptstraße 168, 7122 Gols (AT)

office@deep-nature.at

+43 681 10139055

Like Aurora Cannabis and Canopy Growth, Deep Nature Project GmbH focuses on value chain


Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300

Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)


20. April 2020 | 09:43 CET

Bayer, EXMceuticals, Symrise - investing in the healthcare growth market

  • Healthcare

The Corona Pandemic brings with it many changes. The influences in the supply chain are affecting the economy to the point of stagnation. The lack of contact for people creates challenges in coping with everyday life. The term 'home office' is used in an inflationary way - and often misused, because the difference between 'home office' and 'working from home' is the noise and stress level around it. On top of this, there are also supply bottlenecks for hygiene products, basic foodstuffs and protective equipment. According to a recent statement by the Federal Minister of Economics, Peter Altmaier (CDU), Germany will need 12 billion masks per year to protect the population. But the well-being of the people also depends on other factors.

time to read: 1 minutes by Mario Hose


 

Early stage opportunity

The young Canadian company EXMceuticals focuses on the extraction of pure ingredients from the cannabis plant. The company operates as a supplier for the manufacture of products requiring high quality ingredients. EXMceuticals is operationally located in Lisbon, Portugal and is currently planning to set up a production plant there.

The management around CEO Jonathan Summers sees the European market as the primary sales market. The product world with cannabis as an ingredient is being developed worldwide. The natural active ingredient has already established itself in many areas and the market with pure ingredients is quite lucrative. The EXMceuticals shares enable investors to participate at an early stage with price potential.

Success story with ingredients

One of the most renowned companies in the global flavors and ingredients business is Symrise from Germany. In some regions of the world, the population comes into contact with Symrise products 20 to 30 times a day. The flavors and active ingredients are used in more than 30,000 products from over 6,000 customers in more than 100 countries, and their ingredients and flavors ensure natural nutrition.

Products from Symrise's portfolio can also be found in the cosmetics sector. After a brief period of weakness, the Symrise share price is now back above the level of January 2020.

Group with diversification

The shares of the German Bayer Group can also benefit from the period following the Corona Pandemic, as the demand for medical products will continue to grow in the future. It is possible that there will be Bayer's application products that in the future may limit the spread of viral diseases or alleviate their consequences.

In addition, the acquisition of Monsanto has given the Bayer Group strong roots in the agricultural sector, and the issue of sustainable and healthy nutrition will become an issue that Bayer can address with modern, environmentally friendly products as the population grows around the world. At the moment, the uncertainty surrounding the financial extent of the legal actions for damages in connection with the Monsanto acquisition is creating uncertainties in planning - but the chapter is also finite.


Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

18. June 2020 | 08:40 CET

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

  • Healthcare

Experienced investors assume that the DAX, Germany's leading index, will still reach new highs in 2020. One of the best-known supporters of this scenario is the asset manager Dr. Jens Ehrhardt. Rising markets are supported by the measures taken by central banks and politicians - it is de facto the consequence of the increase in the money supply. This expected development will be of particular interest to those investors who have so far been on the sidelines and have to position themselves or reallocate.

Read

16. June 2020 | 06:30 CET

Gilead, Teva, XPhyto - Global marketing potential

  • Healthcare

The best business models solve problems and are scalable. In this context, the healthcare sector is particularly interesting. The world's population has recently reached 7.8 billion people and for this reason solutions can meet a large potential market with users. Cross-border solutions are needed not only for pandemics, but also for diseases that are not mentioned in the mass media but are nevertheless of great importance. A successful market launch is of equal interest to those affected and investors.

Read

02. June 2020 | 05:58 CET

Memphasys, Moderna, Paion - Investments in solutions with potential

  • Healthcare

Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive this process is, the more capital these companies require from investors. In the race to bring to market preparations or products that improve people's well-being or fulfill desires, the providers of solutions usually have great sales potential and investors may be bought out through a takeover.

Read